LLAI.L
LungLife AI, Inc., a cancer diagnostics company, develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology. It engages in developing LungLB, an AI enhanced, blood-based test to utilize machine learning to identify and count CTCs with reducing operator hands-on time and increasing test performance. The company was formerly known as Cynvenio Biosystems, Inc. and changed its name to LungLife AI, Inc. in May 2019. The company is based in Thousand Oaks, California.
Industry
Medical - Diagnostics & Research
IPO Date
2021-07-08
Stock Exchange
LSE
Ticker
LLAI.L
According to LungLife AI, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.35. This represents a change of -72.13% compared to the average of -1.26 of the last 4 quarters.
The mean historical PE Ratio of LungLife AI, Inc. over the last ten years is -9.90. The current -0.35 PE Ratio has changed 253.45% with respect to the historical average. Over the past ten years (40 quarters), LLAI.L's PE Ratio was at its highest in in the June 2023 quarter at -0.73. The PE Ratio was at its lowest in in the June 2020 quarter at -25.79.
Average
-9.90
Median
-9.06
Minimum
-20.48
Maximum
-2.76
Discovering the peaks and valleys of LungLife AI, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = -2.76
Minimum Annual Increase = -57.30%
Minimum Annual PE Ratio = -20.48
| Year | PE Ratio | Change |
|---|---|---|
| 2023 | -2.76 | -19.89% |
| 2022 | -3.44 | -36.55% |
| 2021 | -5.42 | -57.30% |
| 2020 | -12.70 | -13.09% |
| 2019 | -14.61 | -28.63% |
The current PE Ratio of LungLife AI, Inc. (LLAI.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.87
5-year avg
-7.79
10-year avg
-9.90
LungLife AI, Inc.’s PE Ratio is less than LungLife AI, Inc. (0), less than Oncimmune Holdings plc (-0.23), less than Oxford Cannabinoid Technologies Holdings Plc (-0.19), less than DeepVerge plc (-0.11), less than Kanabo Group Plc (-0.15), less than Ovoca Bio plc (-0.17), less than Hellenic Dynamics Plc (-0.27), less than ReNeuron Group plc (-0.01), less than Totally plc (100.00), greater than Cel AI PLC (-0.56),
| Company | PE Ratio | Market cap |
|---|---|---|
| 0 | N/A | |
| -0.23 | N/A | |
| -0.19 | N/A | |
| -0.11 | N/A | |
| -0.15 | N/A | |
| -0.17 | N/A | |
| -0.27 | N/A | |
| -0.01 | N/A | |
| 100.00 | N/A | |
| -0.56 | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like LungLife AI, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like LungLife AI, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is LungLife AI, Inc.'s PE Ratio?
How is the PE Ratio calculated for LungLife AI, Inc. (LLAI.L)?
What is the highest PE Ratio for LungLife AI, Inc. (LLAI.L)?
What is the 3-year average PE Ratio for LungLife AI, Inc. (LLAI.L)?
What is the 5-year average PE Ratio for LungLife AI, Inc. (LLAI.L)?
How does the current PE Ratio for LungLife AI, Inc. (LLAI.L) compare to its historical average?